VIM and osteosarcoma: Using dual luciferase assay and RIP experiments, we identified miR-483 as a target of NEAT1, and the exogenous expression of NEAT1 reduced miR-483 expression, subsequently upregulating the expression of N-cadherin, Vimentin and Snail and promoting the EMT in osteosarcoma cells.